226 related articles for article (PubMed ID: 9726718)
1. Hemodynamic, cardiac, and electrolyte effects of low-dose aerosolized terbutaline sulfate in asthmatic patients.
Braden GL; Germain MJ; Mulhern JG; Hafer JG; Bria WF
Chest; 1998 Aug; 114(2):380-7. PubMed ID: 9726718
[TBL] [Abstract][Full Text] [Related]
2. Tolerability to high doses of formoterol and terbutaline via Turbuhaler for 3 days in stable asthmatic patients.
Tötterman KJ; Huhti L; Sutinen E; Backman R; Pietinalho A; Falck M; Larsson P; Selroos O
Eur Respir J; 1998 Sep; 12(3):573-9. PubMed ID: 9762782
[TBL] [Abstract][Full Text] [Related]
3. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
4. The influence of the AA 16 beta 2-adrenoceptor polymorphism on systemic and airway responses in asthma.
van Veen A; Weller FR; Wierenga EA; Jansen HM; Jonkers RE
Pulm Pharmacol Ther; 2008; 21(1):73-8. PubMed ID: 17292646
[TBL] [Abstract][Full Text] [Related]
5. Randomised trial of an inhaled beta2 agonist, inhaled corticosteroid and their combination in the treatment of asthma.
Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Wong CS; Taylor DR
Thorax; 1999 Jun; 54(6):482-7. PubMed ID: 10335000
[TBL] [Abstract][Full Text] [Related]
6. Acute relief of exercise-induced bronchoconstriction by inhaled formoterol in children with persistent asthma.
Hermansen MN; Nielsen KG; Buchvald F; Jespersen JJ; Bengtsson T; Bisgaard H
Chest; 2006 May; 129(5):1203-9. PubMed ID: 16685010
[TBL] [Abstract][Full Text] [Related]
7. Dose response to inhaled terbutaline powder and peak inspiratory flow through Turbuhaler in children with mild to moderate asthma.
Ståhl E; Ribeiro LB; Sandahl G
Pediatr Pulmonol; 1996 Aug; 22(2):106-10. PubMed ID: 8875584
[TBL] [Abstract][Full Text] [Related]
8. Tolerability of indacaterol, a novel once-daily beta2-agonist, in patients with asthma: a randomized, placebo-controlled, 28-day safety study.
Yang WH; Martinot JB; Pohunek P; Beier J; Magula D; Cameron R; Owen R; Higgins M
Ann Allergy Asthma Immunol; 2007 Dec; 99(6):555-61. PubMed ID: 18219838
[TBL] [Abstract][Full Text] [Related]
9. Cumulative high doses of inhaled formoterol have less systemic effects in asthmatic children 6-11 years-old than cumulative high doses of inhaled terbutaline.
Kaae R; Agertoft L; Pedersen S; Nordvall SL; Pedroletti C; Bengtsson T; Johannes-Hellberg I; Rosenborg J
Br J Clin Pharmacol; 2004 Oct; 58(4):411-8. PubMed ID: 15373934
[TBL] [Abstract][Full Text] [Related]
10. Bronchodilator tolerance and rebound bronchoconstriction during regular inhaled beta-agonist treatment.
Hancox RJ; Cowan JO; Flannery EM; Herbison GP; McLachlan CR; Taylor DR
Respir Med; 2000 Aug; 94(8):767-71. PubMed ID: 10955752
[TBL] [Abstract][Full Text] [Related]
11. Effects of sequential doses of parenteral terbutaline on plasma levels of potassium and related cardiopulmonary responses.
Clifton GD; Hunt BA; Patel RC; Burki NK
Am Rev Respir Dis; 1990 Mar; 141(3):575-9. PubMed ID: 2178522
[TBL] [Abstract][Full Text] [Related]
12. Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial.
Tattersfield AE; Löfdahl CG; Postma DS; Eivindson A; Schreurs AG; Rasidakis A; Ekström T
Lancet; 2001 Jan; 357(9252):257-61. PubMed ID: 11214127
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of high cumulative doses of the HFA modulite beclomethasone dipropionate/formoterol combination inhaler in asthmatic patients.
Singh D; Piccinno A; Borrill Z; Poli G; Acerbi D; Meuleners L; Woodcock A
Pulm Pharmacol Ther; 2008; 21(3):551-7. PubMed ID: 18321744
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular safety of high doses of inhaled fenoterol and albuterol in acute severe asthma.
Newhouse MT; Chapman KR; McCallum AL; Abboud RT; Bowie DM; Hodder RV; Paré PD; Mesic-Fuchs H; Molfino NA
Chest; 1996 Sep; 110(3):595-603. PubMed ID: 8797398
[TBL] [Abstract][Full Text] [Related]
15. The extrapulmonary effects of increasing doses of formoterol in patients with asthma.
Burgess C; Ayson M; Rajasingham S; Crane J; Della Cioppa G; Till MD
Eur J Clin Pharmacol; 1998 Apr; 54(2):141-7. PubMed ID: 9626918
[TBL] [Abstract][Full Text] [Related]
16. The effect of subcutaneously administered terbutaline on serum potassium in asymptomatic adult asthmatics.
Küng M; White JR; Burki NK
Am Rev Respir Dis; 1984 Feb; 129(2):329-32. PubMed ID: 6364906
[TBL] [Abstract][Full Text] [Related]
17. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
[TBL] [Abstract][Full Text] [Related]
18. Inhaled terbutaline administered via a spacer fully prevents exercise-induced asthma in young asthmatic subjects: a double-blind, randomized, placebo-controlled study.
Dinh Xuan AT; Lebeau C; Roche R; Ferriere A; Chaussain M
J Int Med Res; 1989; 17(6):506-13. PubMed ID: 2697625
[TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle magnesium and potassium in asthmatics treated with oral beta 2-agonists.
Gustafson T; Boman K; Rosenhall L; Sandström T; Wester PO
Eur Respir J; 1996 Feb; 9(2):237-40. PubMed ID: 8777958
[TBL] [Abstract][Full Text] [Related]
20. Randomised placebo controlled trial of beta agonist dose reduction in asthma.
Harrison TW; Oborne J; Wilding PJ; Tattersfield AE
Thorax; 1999 Feb; 54(2):98-102. PubMed ID: 10325911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
